Grants and Contributions:
Title:
Bioinformatics for Drug Discovery Platform
Agreement Number:
904485
Agreement Value:
$91,200.00
Agreement Date:
Apr 1, 2018 - Jun 30, 2019
Description:
48HD employs DNA-encoded libraries and deep sequencing to accelerate the discovery of new drugs. This project will use machine learning to identify interactions of proteins and new chemicals, resulting in models to predict potent new drugs.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Edmonton, Alberta, CA T5K 0H2
Reference Number:
172-2018-2019-Q1-904485
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
719831695
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 61 days.
Amendment Date
Mar 8, 2019
Recipient's Legal Name:
48Hour Discovery Inc.
Federal Riding Name:
Edmonton Centre
Federal Riding Number:
48014
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
541710
Amendments: